HealWELL AI reports after the market closes on November 9. Analysts expect a smaller quarterly loss and higher revenue, though the company has beaten estimates in only one of its last four reported quarters.
HealWELL AI Inc. (TSX: AIDX) will report results for the quarter ended September 30, 2026, after the market closes on November 9. The company has scheduled a conference call for November 10. Analysts expect an adjusted loss of C$0.01 per share and revenue of C$34.31 million, up 13% from a year earlier. The EPS estimate has improved from a loss of C$0.02 per share 30 days ago. The results will show whether recent deployments and contracts are translating into financial progress. HealWELL remains unprofitable, with trailing 12-month EPS of -C$0.09 and a reported profit margin of -23.01%.
Recent earnings trend
HealWELL AI Inc.
AIDX.TO
AIDX.TO
HealWELL AI Inc.
WealthAwesomeMarket cap
$207.30M
52W high
$1.33
52W low
$0.58
1W change
-5.80%
Beta
-0.94
Analyst Price Targets
Based on analyst covering AIDX · as of Nov 3, 2026
Wall Street analysts forecast AIDX stock price to rise 872.8% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.82
+872.8% Upside
Previously C$1.84 on Sep 17, 2026
Current Price
C$0.19
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on AIDX's historical volatility
30-Day Vol
45.4%
Annualized
90-Day Vol
47.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.52
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.58 | C$0.50 – C$0.68 |
| 60 trading days | C$0.55 | C$0.44 – C$0.69 |
| 90 trading days | C$0.52 | C$0.40 – C$0.68 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Analyst coverage: 1 analyst(s) cover this name; upcoming EPS consensus is available.
Beat estimates in 1 of the last 4 comparable quarter(s).
| Fiscal period | Report date | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| 2026-09-30 | 2026-11-09 | — | -0.0200 | — |
| 2026-06-30 | 2026-08-06 | -0.0300 | -0.0200 | -50.0% |
| 2026-03-31 | 2026-05-07 | -0.0200 | -0.0200 | +0.0% |
| 2025-12-31 | 2026-03-19 | -0.0109 | -0.0200 | +45.5% |
| 2025-09-30 | 2025-11-06 | -0.0500 | -0.0200 | -150.0% |
| 2025-06-30 | 2025-08-13 | -0.0300 | -0.0100 | -200.0% |
Investor takeaway: The November 9 earnings report will show whether HealWELL can deliver the expected revenue growth and narrow its per-share loss. The improved EPS estimate is a forecast, not a result. HealWELL beat estimates in one of its last four reported quarters, missed in June 2026 and September 2025, and matched estimates in March 2026. Investors can compare the results with that mixed record and look for signs that announced deployments and agreements are contributing to revenue. See the AIDX stock page for more company data.
C$34.31 million
That’s analysts’ revenue estimate for the quarter ended September 30, 2026, representing expected year-over-year growth of 13%. The EPS consensus is a loss of C$0.01 per share, based on one analyst. The revenue estimate reflects forecasts from 11 analysts. These estimates are not company guidance.
Bull case
Analysts expect revenue of C$34.31 million, up 13% from a year earlier, and an EPS loss of C$0.01, compared with a loss of C$0.05 a year ago. The EPS estimate has also improved over the past 30 days, from -C$0.02 to -C$0.01. Recent company announcements offer some context: HealWELL says its SMART Summary tool is available to more than 400 clinicians in New Brunswick. It has also announced a multi-year agreement to deploy AI search and summary tools across Iowa’s statewide health-information exchange. These developments support the growth story, but the earnings report will show whether they are contributing financially.
Bear case
HealWELL has not consistently beaten EPS estimates. It beat one of its last four, missed two, and matched one. The company also remains unprofitable based on the supplied trailing figures. Its shares closed at C$0.19, below the 50-day moving average of C$0.41 and the 200-day moving average of C$1.34. These figures don’t predict the earnings results, but they highlight the risks facing a small-cap company whose growth plans have yet to show up in reported results. Investors should distinguish product and research announcements from proven revenue or profitability.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
